Medical cannabis company with operations in Israel and Germany, IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC), intends to undertake a non-brokered private placement offering of up to $1,613,000 through the sale of roughly 625,000 units. What Happened: Each unit will be comprised of one share and one share purchase warrant, with each warrant entitling the holder to acquire one additional share at a price equal to a 50% premium to the offering price before the second anniversary of the closing date. The company plans to close the offering in one or more tranches. It will be led by the company’s management team, including Oren Shuster, CEO and chairman of the board of directors and Shmulik Arbel, a director of the company.